Mindset Pharma: Psilocybin-Like Compound MSP-1014 Advancing Towards Phase 1 Clinical Trials Jun 29, 2022
Mindset Pharma Enters Manufacturing Agreement with Leading CDMO to Produce Pharmaceutical Grade Batches of… Jan 25, 2022
Mindset Pharma Further Validates Lead Candidate, MSP-1014, as a Next Generation Psilocybin Analog through Drug… Sep 14, 2021